Evidence map›Paper›PMID 38984929›Full record

ArticleElectrophoresis2024

Comparison between capillary electrophoresis and fluorescence anisotropy competitive immunoassay for glucagon.

Yao Wang, Emily L Skinner, Michael G Roper

Abstract readComparative Study
In one paragraph

Article in Electrophoresis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yao WangDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida, USA.
Emily L SkinnerDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida, USA.
Michael G RoperDepartment of Chemistry and Biochemistry, Florida State University, Tallahassee, Florida, USA.

Funding

Microfluidic Devices to Determine Roles of Islet-Secreted LeptinR01DK080714 · NIDDK · FLORIDA STATE UNIVERSITY · PI ROPER, MICHAEL GABRIEL · 2008 to 2025
$5.5M
NIDDK NIH HHS R01 DK080714NIH HHS R01 DK080714
6 · The paper itself

Abstract

Glucagon plays a crucial role in regulating glucose homeostasis; unfortunately, the mechanisms controlling its release are still unclear. Capillary electrophoresis (CE)- and fluorescence anisotropy (FA)-immunoassays (IA) have been used for online measurements of hormone secretion on microfluidic platforms, although their use in glucagon assays is less common. We set out to compare a glucagon-competitive IA using these two techniques. Theoretical calibration curves were generated for both CE- and FA-IA and results indicated that CE-IA provided higher sensitivity than FA-IA. These results were confirmed in an experiment where both assays showed limits of detection (LOD) of 30 nM, but the CE-IA had ∼300-fold larger sensitivity from 0 to 200 nM glucagon. However, in online experiments where reagents were mixed within the device, the sensitivity of the CE-IA was reduced ∼3-fold resulting in a higher LOD of 70 nM, whereas the FA-IA remained essentially unchanged. This lowered sensitivity in the online CE-IA was likely due to poor sampling by electroosmotic flow from the high salt solution necessary in online experiments, whereas pressure-based sampling used in FA-IA was not affected. We conclude that FA-IA, despite lowered sensitivity, is more suitable for online mixing scenarios due to the ability to use pressure-driven flow and other practical advantages such as the use of larger channels.

Indexed as

Electrophoresis, CapillaryFluorescence PolarizationGlucagonHumansImmunoassayLimit of DetectionGlucagoncapillary electrophoresiscompetitive immunoassayfluorescence anisotropyhormone

Identifiers

PMID38984929
PMCPMC11502243

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.